Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Honghe Fujie lotion for aerobic vaginitis with bacterial vaginosis
ChiCTR2200063436Phase 4Not yet recruiting
- Sponsor
- Tianjin Medical University General Hospital
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of Honghe Fujie Xiye and clindamycin in Aerobic Vaginitis (AV) and bacterial vaginosis (BV) (3 arms), sponsored by Tianjin Medical University General Hospital. Primary endpoint: Microscopic AV and BV scores. Planned start Jan 2021; status: not yet recruiting.
02
Drugs
Honghe Fujie Xiyeclindamycin
03
Conditions
Aerobic Vaginitis (AV)bacterial vaginosis (BV)
Beyond the preview
Go deeper on ChiCTR2200063436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063436.